WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'0301 Infant (under 12 months) mortality rate: 272
GDP / capita (US$): 7'2001 Child (under 5 years) mortality rate: 312

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 33'008  32'521  32'059  31'642  31'277  28'710  24'675  19'799 
Births 750  739  720  696  670  631  740  770 
Surviving infants 731  719  700  676  650  605  697  698 
Pop. less than 5 years 3'422  3'234  3'077  2'984  2'913  3'118  3'457  3'229 
Pop. less than 15 years 9'194  9'035  8'927  8'899  8'902  9'776  9'987  8'716 
Female 15-49 years 9'206  9'176  9'125  9'048  8'962  7'804  5'941  4'534 

Number of reported case

(Click for retrospective incidence data for Morocco)
Diphtheria 43 
Japanese encephalitis
Measles 92  668  982  633  834  7'368  1'577  86'919 
Mumps
Pertussis 72  172  35  15  73  22  83  14'873 
Polio* 52 
Rubella 59 
Rubella (CRS)
Tetanus (neonatal) 28 
Tetanus (total) 23  69  16  20  41  73  81 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Morocco)
Vaccine year result method % card seen                                                
BCG          100  100  99  100  99  97  96 
DTP1          100  100  99  100  99*  98 
DTP3          99  99  99  100  99  95  81 
HepB_BD          100  20  99  99  99  10 
HepB3          99  99  98  98  98  43 
Hib3          99  99  98  100  99 
JapEnc         
MCV          99  99  95  98  98  93  79 
MCV2          10 
PCV1          99  86  91  16 
PCV3          80  72  23 
Pol3          99  99  98  100  99  95  81 
Rota1          95  91  87  17 
Rota_last          90  88  80 
Rubella1         
TT2plus 1994  54  DHS   51  90  64 
PAB         
VAD1          98  80  80  76  76  40 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Morocco)
BCG 99  99  99  99  99  97  96 
DTP1 99  99  99  99  99  98  93 
DTP3 99  99  99  99  99  95  81 
HepB3 99  99  98  98  98  43 
HepB_BD 14  20 
Hib3 99  99  99  99  99 
MCV 99  99  99  98  98  93  79 
MCV2
PAB 89  89  89  89  87  86  66 
PCV3 80  72  23 
Pol3 99  99  98  99  99  95  81 
Rota_last 90  88  80 

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 89
From 80 to 89% 11
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
Measles 9 months; Yes
OPV 1, 2, 3, 4, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 3 months; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2008-2012  2008-2012  2008-2012  2010-2012  2009-20011  2006-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 81  81  81  68  68  68  68 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 81  81  81  68  68  68  68 
Nº districts with DTP3 coverage >=80% number 81  80  79  68  68  67  19 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  99  98  100  100  99  28 
Nº districts with measles (MCV1) coverage >=95% number 51  65  47  45  39  32   
% of districts with MCV1 coverage >=95% From 0 to 100% 63  80  58  66  57  47   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%     100  92  100  100  100 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.